Additivity Study: Additive Effect on Eye Pressure of Azopt and Alphagan P to Travatan

NACompletedINTERVENTIONAL
Enrollment

200

Participants

Timeline

Start Date

September 30, 2003

Study Completion Date

October 31, 2005

Conditions
Open Angle GlaucomaOcular HypertensionPseudoexfoliation Syndrome
Interventions
DRUG

Travatan

DRUG

Azopt

DRUG

Alphagan P

Trial Locations (21)

10029

Mount Sinai School of Medicine, New York

11714

Eyecare Ophthalmology PC, Bethpage

19107

Wills Eye Institute, Philadelphia

19114

The Keystone Eye Associates, Philadelphia

26506

West Virginia University Eye Institute, Morgantown

30322

Emory Healthcare Eye Center, Atlanta

30342

Omni Eye Services, Atlanta

32610

University of Florida, Gainesville

39564

Mississippi Eye Associates, Ocean Springs

46202

Indiana University School of Medicine, Indianapolis

48201

Kresge Eye Institute, Detroit

60611

Northwestern University, Chicago

60612

University of Illinois Eye and Ear Infirmary, Chicago

73104

Dean McGee Eye Institute, Oklahoma City

75231

Glaucoma Associates of Texas, Dallas

77030

Baylor College of Medicine, Houston

Hermann Eye Center, Houston

77479

Lone Star Eye Associates, Sugarland

90033-4666

Doheny Eye Institute, Los Angeles

06518

The Eye Center, Hamden

02114

Glaucoma Consultation Service, Boston

Sponsors

Collaborators (1)

All Listed Sponsors
collaborator

Alcon Research

INDUSTRY

lead

Hermann Eye Center

OTHER